Neuen, B. L., Oshima, M., Agarwal, R., Arnott, C., Cherney, D. Z., Edwards, R., . . . Heerspink, H. J. L. (2022). Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials. Circulation (New York, N.Y.), 145(19), 1460. https://doi.org/10.1161/CIRCULATIONAHA.121.057736
Chicago-Zitierstil (17. Ausg.)Neuen, Brendon L., et al. "Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials." Circulation (New York, N.Y.) 145, no. 19 (2022): 1460. https://doi.org/10.1161/CIRCULATIONAHA.121.057736.
MLA-Zitierstil (9. Ausg.)Neuen, Brendon L., et al. "Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials." Circulation (New York, N.Y.), vol. 145, no. 19, 2022, p. 1460, https://doi.org/10.1161/CIRCULATIONAHA.121.057736.